A Letter from the Founders of Fortell

News
/
December 2025

Hear at last: firmly better hearing aids.

We grew up watching our grandparents struggle with hearing aids. In quiet rooms, their hearing aids were effective, but anywhere else, they’d struggle. At restaurants and family dinners they withdrew from the conversations they once led (and loved). Their hearing aids sucked and the consequences were severe.

We started Fortell with the conviction that AI could radically improve hearing aids–because hearing loss shouldn’t mean losing connection with the people you love. After 5 years in development, our Fortell AI Hearing Aids are ready and you can buy them (with a prescription) today at our flagship audiology clinic in New York City.

A bit of background: ~1 in 8 Americans has hearing loss, but fewer than 16% of people with hearing loss wear hearing aids. Hearing loss is typically “sensorineural,” which means it is as much a problem with the ear’s ability to hear as it is with the brain’s ability to understand. The ear-portion is straightforward: sounds must be amplified in order to be heard. The brain-portion is more pernicious, making it challenging for people with hearing loss to follow conversation in background noise.

Over the last 30 years, hearing aid manufacturers have gotten pretty good at addressing the ear-portion of the problem: high-end hearing aids are small, run all day, and can be programmed by an audiologist to ensure wearers won’t miss quiet sounds.

But the brain-portion is the hard part. Healthy hearing people have an amazing ability to tune out background noise and focus-in on the sounds they care about. But hearing loss impairs this ability, so people with hearing loss need easier, quieter environments for their conversations. At a technical level, they require easier signal-to-noise ratio (SNR) environments. But today’s hearing aids don’t meaningfully improve SNR because they don’t know the difference between speech and noise. Their algorithms process sound on the basis of frequency, amplitude, and time, but in these domains, conversation and noise are indistinguishable. To conventional hearing aids, “signal” and “noise” are both just sound, so both get amplified.

By contrast, Fortell AI Hearing Aids selectively amplify the speech a wearer is trying to understand. Executing on this simple goal required a completely new technical approach with two novel pillars:

  1. Large neural networks that understand which sounds should be amplified, and which should be attenuated.
  2. Novel custom chips that bring our huge AI models into tiny hearing aids without discernible latency or compromised battery life.

The net effect is a pair of hearing aids that makes you feel like you’re having a conversation in a quiet room, even when you’re in a noisy one. Fortell AI Hearing Aids are unique in the level to which they address both the ear AND brain aspects of hearing loss, ensuring conversations are both heard *and* understood.

Getting here was hard:

  • We spent years field testing with over 100 of the most discerning hearing aid wearers in the world (Oscar winners, Grammy winners, Tony winners, Fortune 100 CEOs). We didn’t stop iterating until they refused to return our prototypes.
  • We worked with outside academics and independent labs to evaluate our technology in randomized, controlled trials where wearers of our device understood 10x more words, and preferred them to every top-of-the-line competitor.
  • We scoured the world for the most brilliant audiologists, hired them, and built them a state-of-the art clinic on Park Avenue with only one goal: treat every patient like a member of your own family.

To everyone out there struggling with today’s hearing aids: sorry it took so long. We’re ready for you: hear at last.

Matt de Jonge, Andrew Casper, Cole Morris, Igor Lovchinsky
Founders of Fortell

Read the full study

Latest from Fortell
Clinical Research
/
December 2025
About Hearing Loss
About Hearing Loss
Clinical Research
/
December 2025
In Blinded Trial, 95% of Participants Preferred Fortell Over Top Competitors
In Blinded Trial, 95% of Participants Preferred Fortell Over Top Competitors
Clinical Research
/
December 2025
Clinical Trial Demonstrates Breakthrough Intelligibility Gains with Fortell
Clinical Trial Demonstrates Breakthrough Intelligibility Gains with Fortell